SIROLIMUS

13673 reported adverse events

Drug classes: Kinase Inhibitor [EPC] mTOR Inhibitor Immunosuppressant [EPC]

These side effects are most commonly reported by patients taking SIROLIMUS:

# Side effect Count
0 OFF LABEL USE 2127
1 DRUG INEFFECTIVE 1150
2 PRODUCT USE IN UNAPPROVED INDICATION 792
3 PYREXIA 535
4 DIARRHOEA 530
5 PNEUMONIA 501
6 DRUG INTERACTION 450
7 ACUTE KIDNEY INJURY 444
8 THROMBOTIC MICROANGIOPATHY 386
9 TRANSPLANT REJECTION 384
See all common reactions for SIROLIMUS

SIROLIMUS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COW POX 9 0.8182
1 PIK3CA RELATED OVERGROWTH SPECTRUM 10 0.6250
2 STAPHYLOCOCCAL MEDIASTINITIS 10 0.4545
3 SKIN SQUAMOUS CELL CARCINOMA METASTATIC 25 0.2632
4 AVIAN INFLUENZA 14 0.2188
5 SMOOTH MUSCLE CELL NEOPLASM 90 0.2153
6 FOCAL GLOMERULOSCLEROSIS 22 0.2075
7 KAPOSI SARCOMA INFLAMMATORY CYTOKINE SYNDROME 12 0.2034
8 SKIN GRAFT REJECTION 9 0.1579
9 PROPIONIBACTERIUM INFECTION 16 0.1509
See all enriched reactions for SIROLIMUS